TL;DR - A mass tort claim is an individual lawsuit filed by many people injured by the same product; each plaintiff keeps their own case and their own damages calculation. - Eligibility requires a qualifying injury, documented product exposure, and filing within the applicable statute of limitations. - Statutes of limitations for mass tort claims typically run 2 to 3 years from the date of injury or discovery; missing the deadline permanently bars the claim. - Filing means retaining an attorney, who handles the complaint and joins the appropriate MDL on your behalf. - Most mass tort claims resolve through a global settlement, not an individual trial; the full process takes 4 to 7 years on average from MDL formation to payment.
Mass tort claims give injured people a way to seek compensation from a company whose product caused the same type of harm across thousands of individuals. The process can feel opaque: there is a defendant, an injury, a lawsuit, and eventually a settlement check, but what happens in between is rarely explained in plain language. This guide covers what mass tort claims are, who qualifies, how the filing process works, what happens inside an MDL, and what claimants should expect from the timeline and costs.
What is a mass tort claim?
A mass tort claim is an individual personal injury lawsuit filed against the same defendant by a large group of people who suffered similar injuries from the same product, drug, or environmental exposure. Unlike a class action, each plaintiff in a mass tort retains their own separate case with individually calculated damages.
The practical consequence of this structure is that two people injured by the same product can receive substantially different compensation based on injury severity, length of exposure, and the quality of their medical records. The shared element is the defendant and the product, not the outcome. For a full explanation of how this differs from a class action, see the comparison guide on this site.
Who qualifies to file a mass tort claim?
Eligibility for a mass tort claim requires three things: a qualifying injury, documented exposure to the defendant's product, and filing within the applicable statute of limitations.
Qualifying injury is defined by each MDL's specific criteria. In the Roundup litigation, qualifying injuries include non-Hodgkin's lymphoma and other cancers linked to glyphosate herbicide. In the talcum powder MDL, qualifying injuries are ovarian cancer and mesothelioma. In the Depo-Provera litigation, the qualifying injury is intracranial meningioma linked to long-term use of the injectable contraceptive. In the AFFF firefighting foam MDL, qualifying injuries include bladder cancer, kidney cancer, and testicular cancer. Each MDL publishes specific eligibility criteria that determine which plaintiffs may participate.
Documented exposure means the plaintiff can demonstrate they actually used the product during the qualifying period. Prescription records, purchase receipts, military service records, and employment records can all serve as proof. This documentation matters more than many claimants expect: two plaintiffs with the same diagnosis can receive meaningfully different settlement offers based on the completeness of their exposure evidence.
Statute of limitations sets the hard deadline for filing. A claim filed after the limitations period has run is permanently barred, regardless of injury severity. The next section covers this in detail.
What is the statute of limitations for mass tort claims?
The statute of limitations for mass tort claims is typically 2 to 3 years, varying by state and by the specific nature of the injury. Missing this deadline permanently bars a claim.
Most states apply a "discovery rule" in personal injury and mass tort cases: the limitations clock starts not when the exposure occurred, but when the plaintiff knew or reasonably should have known that the injury was linked to the defendant's product. This rule is significant in cases where the injury develops years after exposure. A plaintiff diagnosed with cancer in 2024 from a product used a decade earlier may find the limitations period has only recently begun.
Some cases alter the limitations rules through specific legislation. Camp Lejeune claims operated under the PACT Act, which opened a two-year filing window from August 2022 to August 2024 for claims that would otherwise have been barred under federal sovereign immunity law. Zantac claims in some states are subject to ongoing disputes about when the discovery clock began running.
Cornell LII provides state-by-state guidance on general personal injury limitations periods. For any specific MDL, the applicable discovery rule, any tolling agreements negotiated during litigation, and any case-specific deadlines should be confirmed with a plaintiff attorney, since these can extend or modify the baseline state deadline.
Documentation requirements for mass tort claims
Filing a mass tort claim successfully requires medical records confirming the diagnosis, evidence of product use during the qualifying period, and a completed plaintiff fact sheet submitted to the MDL.
The core documents most MDLs require include:
- Medical records confirming the qualifying diagnosis, including pathology or imaging reports where applicable
- Physician or specialist records linking the diagnosis to the plaintiff's history of product use
- Exposure proof: prescription records, purchase records, employment records, or military service records depending on the case
- A plaintiff fact sheet, the standardized questionnaire that every MDL requires plaintiffs to complete during case-specific discovery, covering injury history, product use, and medical treatment
Plaintiff attorneys routinely assist with document collection. The completeness of this documentation directly affects how a claim is scored under the settlement matrix that determines individual compensation once a global settlement is reached. A well-documented claim scores higher than an identical injury with incomplete records.
How do you file a mass tort claim?
Filing a mass tort claim means retaining a plaintiff attorney, completing an intake process, and having the attorney file the complaint and enroll the case in the appropriate MDL.
The steps follow a fixed sequence:
1. Retain an attorney. Mass tort attorneys work on contingency: no fee unless there is a recovery. Initial consultations cost nothing. The attorney evaluates whether the injury and exposure meet the eligibility criteria for an active MDL.
2. Complete the intake. The attorney gathers exposure and medical history, requests relevant records, and confirms the case clears the minimum threshold for the MDL's eligibility requirements.
3. File the complaint. The attorney files the complaint in the appropriate federal or state court. Cases filed after an MDL is established are typically transferred automatically by the JPML to join the consolidated proceeding. Cases filed before an MDL exists may be consolidated later when the Panel acts on a transfer motion.
4. Submit the plaintiff fact sheet. Early in each plaintiff's case, the MDL requires completion of a standardized questionnaire covering injury, diagnosis, product use, and medical treatment history. This document forms the foundation of how the individual claim is evaluated.
5. Respond to case-specific discovery. Individual cases remain active within the MDL. The attorney handles any depositions, supplemental document requests, or case-specific proceedings that arise.
The full nine-stage process from initial injury through final payment is covered in detail on the how it works page of this site.
What happens after your claim joins an MDL
After joining an MDL, your case enters the shared pre-trial structure managed by a federal transferee judge and a lead counsel committee. Most plaintiffs have limited day-to-day visibility into this phase, but their claim is actively moving forward.
Lead counsel handles coordinated discovery on behalf of all plaintiffs: obtaining internal company documents, deposing corporate executives, retaining expert scientific witnesses, and arguing Daubert motions that determine which expert testimony will be admissible at trial. Individual plaintiffs retain their own attorneys, who draw on all shared work while managing their specific claim.
Bellwether trials then establish what the claims are worth. A small number of representative cases go to jury verdict. The pattern of results tells both sides what a global settlement should look like. After settlement is reached, individual plaintiffs submit documentation to a claims administrator, who scores each claim against a settlement matrix and issues individual compensation offers.
Most mass tort claims resolve through this global settlement process rather than through individual trials. A plaintiff can in theory reject a settlement offer and pursue their case individually, but this is uncommon once a global deal is in place. The bellwether trial guide on this site explains how trial verdicts drive the settlement negotiations that follow.
How long do mass tort claims take to resolve?
Mass tort claims typically take 4 to 7 years from MDL formation to final payment, with some cases running longer depending on the litigation's complexity and the number of plaintiffs.
The timeline is driven by three main phases. Discovery typically spans one to three years after MDL formation. Bellwether trials are scheduled once discovery concludes and take an additional year or more to produce a pattern of results. Claims administration, the process of scoring and paying individual claims after a global settlement, can extend one to three years beyond the settlement announcement.
For cases in early stages as of 2026 (Depo-Provera, Bard PowerPort, and GLP-1/Ozempic), claimants should anticipate the process extending well past 2027 before a global resolution is available. The active cases page on this site tracks current timelines and bellwether trial schedules for all covered MDLs.
Attorney fees in mass tort cases
Mass tort attorneys work on contingency: they receive a percentage of any recovery (typically 33 to 40 percent) and nothing if the case produces no settlement or verdict. No payment is owed up front.
Two types of fees apply in most MDL recoveries.
Individual contingency fees cover the plaintiff's own attorney for intake, case preparation, and ongoing representation. The specific percentage is set in the retainer agreement signed at the start of representation and typically falls between 33 and 40 percent of the gross recovery.
Common benefit fees of approximately 4 to 8 percent may also apply, compensating the lead counsel attorneys who managed shared pre-trial work (coordinated discovery, expert witnesses, Daubert briefing) for all plaintiffs in the MDL. These fees are typically deducted from the overall settlement fund before individual distributions rather than added on top of the individual attorney percentage.
Medical liens represent a third deduction. Medicare, Medicaid, and private insurers who paid for treatment related to the qualifying injury have a legal right to reimbursement from any settlement recovery. A plaintiff who receives a gross settlement offer of $150,000 might net $75,000 to $90,000 after attorney fees and lien resolution. The specific amounts depend on the retainer agreement in place and the size of outstanding medical liens. A full breakdown of the deduction sequence is available on the how it works page of this site.
The information on mass-torts.com is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by using this website. Laws vary by state and jurisdiction. For advice about your specific situation, consult a licensed attorney in your jurisdiction. mass-torts.com is not a law firm and does not provide legal representation.